Pharmaceuticals in Japan

Pharmaceuticals in Japan


  • Products Id :- OHMF4271
  • |
  • Pages: 39
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pharmaceuticals in Japan

Summary

Pharmaceuticals in Japan industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Japan pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Japanese pharmaceuticals market had total revenues of USD 68.2bn in 2017, representing a compound annual growth rate (CAGR) of 0.2% between 2013 and 2017.

- The greatest challenge to the Japanese pharmaceutical market is developing drugs for an aging population at a price which is acceptable to the Japanese taxpayer and government.

- In a similar fashion to other developed countries, the government has begun a number of initiatives to control healthcare spending. Consequently there are pressures to keep a lid on health expenditure, which helps to explain slow growth over recent years.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Japan

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Japan

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Japan pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the Japan pharmaceuticals market by value in 2017?

- What will be the size of the Japan pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the Japan pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in Japan's pharmaceuticals market?



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 16

New entrants 17

Threat of substitutes 19

Degree of rivalry 20

Leading Companies 22

Astellas Pharma Inc. 22

Daiichi Sankyo Co Ltd 25

Mitsubishi Tanabe Pharma Corporation 28

Takeda Pharmaceutical Company Limited 31

Macroeconomic Indicators 34

Country data 34

Methodology 36

Industry associations 37

Related MarketLine research 37

Appendix 38

About MarketLine 38

List of Figures

Figure 1: Japan pharmaceuticals market value: USD billion, 2013-17

Figure 2: Japan pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: Japan pharmaceuticals market share: % share, by value, 2017

Figure 4: Japan pharmaceuticals market value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in Japan, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in Japan, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in Japan, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2017

Figure 11: Astellas Pharma Inc.: revenues & profitability

Figure 12: Astellas Pharma Inc.: assets & liabilities

Figure 13: Daiichi Sankyo Co Ltd: revenues & profitability

Figure 14: Daiichi Sankyo Co Ltd: assets & liabilities

Figure 15: Mitsubishi Tanabe Pharma Corporation: revenues & profitability

Figure 16: Mitsubishi Tanabe Pharma Corporation: assets & liabilities

Figure 17: Takeda Pharmaceutical Company Limited: revenues & profitability

Figure 18: Takeda Pharmaceutical Company Limited: assets & liabilities

List of Tables

Table 1: Japan pharmaceuticals market value: USD billion, 2013-17

Table 2: Japan pharmaceuticals market geography segmentation: USD billion, 2017

Table 3: Japan pharmaceuticals market share: % share, by value, 2017

Table 4: Japan pharmaceuticals market value forecast: USD billion, 2017-22

Table 5: Astellas Pharma Inc.: key facts

Table 6: Astellas Pharma Inc.: key financials (USD )

Table 7: Astellas Pharma Inc.: key financials (JPY)

Table 8: Astellas Pharma Inc.: key financial ratios

Table 9: Daiichi Sankyo Co Ltd: key facts

Table 10: Daiichi Sankyo Co Ltd: key financials (USD )

Table 11: Daiichi Sankyo Co Ltd: key financials (JPY)

Table 12: Daiichi Sankyo Co Ltd: key financial ratios

Table 13: Mitsubishi Tanabe Pharma Corporation: key facts

Table 14: Mitsubishi Tanabe Pharma Corporation: key financials (USD )

Table 15: Mitsubishi Tanabe Pharma Corporation: key financials (JPY)

Table 16: Mitsubishi Tanabe Pharma Corporation: key financial ratios

Table 17: Takeda Pharmaceutical Company Limited: key facts

Table 18: Takeda Pharmaceutical Company Limited: key financials (USD )

Table 19: Takeda Pharmaceutical Company Limited: key financials (JPY)

Table 20: Takeda Pharmaceutical Company Limited: key financial ratios

Table 21: Japan size of population (million), 2013-17

Table 22: Japan gdp (constant 2005 prices, USD billion), 2013-17

Table 23: Japan gdp (current prices, USD billion), 2013-17

Table 24: Japan inflation, 2013-17

Table 25: Japan consumer price index (absolute), 2013-17

Table 26: Japan exchange rate, 2013-17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 350 INR 25344
Site License
USD 700 INR 50687
Corporate User License
USD 1050 INR 76031

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com